FdaApplication
ANDA 090071
Identifiers
- fda_app_no: ANDA090071
Properties
| Property | Value |
|---|---|
| applicant_name | VALEANT PHARMACEUTICALS NORTH AMERICA LLC |
| application_type | ANDA |
| approval_date | 2011-04-15 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
| VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 150MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
| VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
3 products